The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AKLIEF (Galderma Australia Pty Ltd)
Product name
AKLIEF
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
166 (175 working days)
Active ingredients
trifarotene
Registration type
NCE/NBE
Indication
AKLIEF (cream) is indicated for the topical treatment of Acne Vulgaris of the face and/or the trunk in patients from 12 years of age and older, when many comedones, papules and/or pustules are present.